FindTrial
Sign In

Establishment and validation of a predictive model for residual lesions after LEEP operation in patients with high-grade intraepithelial neoplasia of the cervix

Establishment and validation of a predictive model for residual lesions after LEEP operation in patients with high-grade intraepithelial neoplasia of the cervix

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030183
Enrollment
Unknown
Registered
2020-02-24
Start date
2020-02-18
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-grade intraepithelial neoplasia of the cervix

Interventions

LEEP&#32
operation
Gold Standard:Pathologic diagnosis
Index test:a&#32
predictive&#32
model&#32
for&#32
residual&#32
lesions&#32
after&#32

Sponsors

International Peace Maternal and Child Health Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 90 Years

Inclusion criteria

Inclusion criteria: All patients treated with LEEP for high-grade cervical intraepithelial neoplasia (HSIL) will be included in the study

Exclusion criteria

Exclusion criteria: Lost to Follow-Up

Design outcomes

Primary

MeasureTime frame
Positive for residual lesion;SEN, SPE, ACC, AUC of ROC;—

Secondary

MeasureTime frame
Three-dimensional vascular parameters of cervical blood flow;—

Countries

China

Contacts

Public ContactLin Jing

International Peace Maternal and child health center

emilyaya@126.com+86 13601733893

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026